Intelligence Profile
Research Papers
As of now, there are no published research papers or completed clinical trials available on "Colipral" according to PubMed, which suggests that evidence regarding this therapy is still developing.
Currently, three clinical trials are registered:
Prevention of Recurrent Cystitis: This trial is focused on menopausal women and aims to evaluate the effectiveness of Colipral, a probiotic strain known as Escherichia Coli 5C (ECP24®), in preventing recurrent bladder infections. The trial is not yet recruiting, and specific details such as sample size or study duration have not been disclosed.
Gut Microbiota Composition in Ulcerative Colitis: This study will assess how Colipral affects gut microbiota in patients with ulcerative colitis who are in remission and experiencing functional disorders. Like the first trial, it is not yet recruiting, with no additional design details available.
Post-Colonoscopy Gastrointestinal Symptoms: This trial aims to determine the effects of Escherichia Coli 5C (Colipral®) on gastrointestinal symptoms following a colonoscopy. Recruitment for this study has not started, and no further information about the sample size or methodology is available.
Each of these studies is still in the early stages with no recruitment started, indicating that conclusions around the efficacy and safety of Colipral cannot yet be drawn.
Disclaimer: This content is informational and not a substitute for professional medical advice. Always consult your healthcare provider for guidance tailored to your health circumstances.